Your best medicine news resource
May 15th 2008Drug InformationBio-terrorism
A survey of US hospitals and emergency rooms suggests they would not be able to cope with the surge of casualties that might follow a terror attack. The one day survey of 34 major hospitals was carried out by a House of Representatives oversight committee that is investigating the potential impact of plans by the Bush administration to cut Medicaid funding.
More: continued here
May 15th 2008Drug InformationBio-terrorism
If you have a nagging feeling that life is getting increasingly hazardous, you may be interested in the new book, “Operational Risk Management,” by Mark D. Abkowitz, professor of civil and environmental engineering at Vanderbilt University.The book contains 15 case studies of major disasters, including September 11, Hurricane Katrina and the losses of the Challenger and Columbia space shuttles.
More: continued here
May 15th 2008Drug InformationBio-terrorism
Emergent BioSolutions Inc. (NYSE: EBS) announced that it has completed the acquisition of all assets and rights related to a recombinant protective antigen (rPA) anthrax vaccine product candidate and related technology from VaxGen, Inc. Recent improvements to the rPA vaccine, specifically related to stability, suggests that it is well positioned to be a leading candidate for an award under a request for proposal (RFP) recently issued by the U.S. Department of Health and Human Services (HHS).
More: continued here
May 15th 2008Drug InformationBio-terrorism
The La Jolla Institute for Allergy & Immunology (LIAI) has received a $7.1 million grant from the National Institutes of Health (NIH) to fund safety and effectiveness testing of an antibody treatment that quickly fights the smallpox virus. The treatment could be the nation’s first line of defense in protecting against a terrorist-originated smallpox outbreak and may eventually be stockpiled nationwide alongside the smallpox vaccine.
More: continued here
May 15th 2008Drug InformationBio-terrorism
Highlighting North Carolina State University’s leadership in hazard and disaster studies, NC State’s Dr. Thomas Birkland was awarded a grant from the National Science Foundation to lead a nationwide effort to recruit and mentor young researchers to study disasters such as Hurricane Katrina and the September 11 terrorist attacks.The effort will focus on pairing newly minted Ph.D.
More: continued here
May 15th 2008Drug InformationBio-terrorism
There’s safety (and security) in numbers… especially when those numbers are random. That’s the lesson learned from a DHS-sponsored research project out of the University of Southern California (USC). The research is already helping to beef up security at LAX airport in Los Angeles, and it could soon be used across the country to predict and minimize risk.
More: continued here
May 15th 2008Drug InformationBio-terrorism
The La Jolla Institute for Allergy & Immunology (LIAI) has received a $7.1 million grant from the National Institutes of Health (NIH) to fund safety and effectiveness testing of an antibody treatment that quickly fights the smallpox virus. The treatment could be the nation’s first line of defense in protecting against a terrorist-originated smallpox outbreak and may eventually be stockpiled nationwide alongside the smallpox vaccine.
More: continued here
May 15th 2008Drug InformationBio-terrorism
If you use one of America’s top Internet service providers, you may share server space with an organization that enables worldwide terrorism, says a new study by Tel Aviv University.A workshop on terrorist organizations and the Internet was organized for the North American Treaty Organization (NATO) by the Netvision Institute for Internet Studies (NIIS) and the Interdisciplinary Center for Technology Analysis & Forecasting, both of Tel Aviv University.
More: continued here
May 15th 2008Drug InformationBio-terrorism
Two American companies are teaming up for second-round test-phase production of a FDA-designated “fast track” drug candidate to treat smallpox, a deadly virus that is feared to be able to reach people through acts of bio-warfare or bio-terrorism.
More: continued here
Apr 13th 2008Drug InformationBio-terrorism
Biological Psychiatry, in its upcoming April 15th issue, is publishing a critically important commentary written by its Editors, members of its Editorial Committee, and its Editorial Board. This commentary is an urgent public statement, highlighting the increasing problem of terrorist acts, by individuals affiliated with groups such as the Animal Liberation Front, against investigators conducting research in non-human primates in the United States.
More: continued here
Your best medicine news resource
